Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Current Leases (2016 - 2017)

Historic Current Leases for Neurocrine Biosciences (NBIX) over the last 8 years, with Q4 2017 value amounting to $62000.0.

  • Neurocrine Biosciences' Current Leases fell 7372.88% to $62000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $62000.0, marking a year-over-year decrease of 7372.88%. This contributed to the annual value of $62000.0 for FY2017, which is 7372.88% down from last year.
  • As of Q4 2017, Neurocrine Biosciences' Current Leases stood at $62000.0, which was down 7372.88% from $121000.0 recorded in Q3 2017.
  • Neurocrine Biosciences' 5-year Current Leases high stood at $556000.0 for Q2 2015, and its period low was $62000.0 during Q4 2017.
  • Its 5-year average for Current Leases is $352900.0, with a median of $412500.0 in 2013.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 8438.66% in 2013, then tumbled by 7372.88% in 2017.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Current Leases stood at $416000.0 in 2013, then increased by 12.26% to $467000.0 in 2014, then dropped by 8.35% to $428000.0 in 2015, then tumbled by 44.86% to $236000.0 in 2016, then plummeted by 73.73% to $62000.0 in 2017.
  • Its Current Leases was $62000.0 in Q4 2017, compared to $121000.0 in Q3 2017 and $181000.0 in Q2 2017.